In 2025, the toxicology testing market size is projected to surge significantly, paving the way for safer pharmaceuticals, cleaner food products, and enhanced public health protections. Forecasts show an impressive market expansion of USD 32.58 billion between 2023 and 2028, growing at a robust CAGR of 15.61%.
This growth is powered by regulatory shifts, technological innovation, and urgent demands across the pharmaceutical, food, and chemical industries. In this in-depth analysis, discover how global demand, predictive science, and high-throughput technologies are reshaping the future of toxicology.
For more details about the industry, get the PDF sample report for free
Toxicology testing refers to the scientific assessment of adverse effects caused by chemical substances on living organisms. This market serves a critical role in drug development, food safety, forensic investigations, and industrial compliance.
At the heart of this market is the drive for:
Preclinical drug evaluations to meet FDA and EMA standards
Ensuring consumer protection through food and chemical safety screening
Advanced screening technologies like in vitro testing, omics, and computational models
The testing process involves analyzing biological samples such as urine, blood, saliva, and hair, using techniques ranging from cellular assays to in silico simulations.
The Toxicology Testing Market is expanding significantly due to growing demand for comprehensive safety assessment in drug safety, food safety, and chemical testing. Traditional methods like in vivo testing and more advanced techniques such as in vitro testing, in silico testing, and 3D cell culture are being widely adopted. The use of cell culture and high-throughput screening enhances efficiency in identifying toxicity endpoints such as acute toxicity, dermal toxicity, ocular toxicity, and systemic toxicity. Testing methods including genotoxicity testing, micronucleus assay, comet assay, and the Ames test are commonly employed to detect DNA damage and chromosomal aberration. Furthermore, specialized evaluations like carcinogenicity testing, neurotoxicity testing, and skin sensitization contribute to a more detailed toxicity profile, supporting regulatory compliance across industries. The incorporation of organ-on-chip models represents a major innovation, helping to replicate human physiology more accurately during preclinical studies.
Market growth is supported by a dynamic group of companies adopting new technologies and expanding global reach. These key players are setting benchmarks in service delivery and innovation:
Thermo Fisher Scientific Inc. – Powering high-throughput screening with molecular imaging tools
Abbott Laboratories – Known for integrated toxicology platforms across clinical diagnostics
Eurofins Scientific SE – A major global player in laboratory testing and regulatory services
Quest Diagnostics Incorporated – Focusing on accessible drug and workplace testing solutions
Charles River Laboratories International Inc. – Preclinical and early-phase testing leader
BioIVT LLC – Specializes in human-based biological samples for in vitro research
Each company contributes to the ecosystem of predictive toxicology, remote diagnostics, and real-time analytics.
See What’s Inside: Access a Free Sample of Our In-Depth Market Research Report.
Pharmaceutical Industry: The largest segment, heavily regulated and research-intensive
Food Industry: Driven by global food safety standards and compliance needs
Chemical Industry and Others: Testing industrial exposure and workplace safety
The pharmaceutical industry alone accounted for USD 5.92 billion in 2018 and is projected to outpace all others by 2028 due to stringent regulatory demands and rising drug discovery efforts.
Cell Culture Technology – Foundation for in vitro drug safety tests
High Throughput Screening (HTS) – Speeds up chemical and genetic analysis
Molecular Imaging – Tracks toxic effects in real-time at the cellular level
OMICS Technology – Includes genomics, proteomics, and metabolomics for multi-dimensional testing
North America (U.S. and Canada) – Dominates with 43% market share
Europe (Germany, UK) – Leads in ethical compliance and non-animal testing innovations
Asia-Pacific (China) – Rapid growth from pharmaceutical and food processing demand
Rest of World (ROW) – Emerging focus on regulatory modernization
Public and regulatory pressure against animal testing has accelerated adoption of predictive toxicology tools, such as:
In silico modeling
Toxicogenomics
Ex vivo testing systems
These techniques provide faster, ethical, and cost-effective results, enhancing decision-making in preclinical studies.
The combination of genomics, proteomics, and metabolomics is enabling a shift to personalized toxicology, reducing trial and error in drug development and offering real-time insights into adverse effects.
Telehealth and digital diagnostics are transforming how samples are collected and analyzed, with increasing demand for:
Remote and mobile testing kits
Cloud-based toxicology reporting systems
AI-powered data analysis platforms
As public health policies shift focus toward mental wellness and addiction recovery, toxicology testing has become central to rehabilitation centers, workplace safety programs, and clinical trials.
With robust infrastructure, regulatory backing (FDA), and leading research institutions, North America is expected to maintain dominance. The U.S. is also leading in drug innovation and forensic applications.
Strong ethical frameworks have made Europe a hub for non-animal testing and in vitro innovation. Investment in EU REACH regulations continues to drive demand.
Countries like China and India are rapidly scaling pharmaceutical production and food exports. Toxicology testing is critical to gaining international market access.
Shortage of Skilled Professionals: Advanced testing methods require highly trained technicians, and the talent gap is growing
Data Management Complexity: High-throughput technologies generate vast amounts of complex biological data
Evolving Regulatory Landscape: Companies must adapt to country-specific toxicology standards
Public Trust and Ethical Testing: Brands must balance speed with transparency and ethical considerations
Get more details by ordering the complete report
Advanced research in the Toxicology Testing Market focuses on refining methodologies and enhancing analytical capabilities through technologies like omics technology, molecular imaging, and flow cytometry. The integration of bioinformatics tools, toxicogenomics, and predictive toxicology enables better understanding of biological activity and mechanisms of toxicity. Techniques such as cell-based assays, label-free detection, and high-content screening provide more detailed insights into receptor binding, enzyme toxicity, and the effectiveness of potential therapies. Tools like mass spectrometry and biomarker analysis play crucial roles in identifying early toxicity indicators. Additionally, advances in automated screening and robust data management systems are streamlining toxicology workflows, allowing for quicker and more accurate results. The continuous evolution of testing platforms ensures that the market remains aligned with industry standards for safer and more ethical toxicity evaluation.
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
